Across TCGA pan-cancer cohorts, RPS14P5 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RPS14P5 data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPS14P5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS14P5 expression acts as an unfavorable survival marker, although some lineages such as UVM and BLCA show a favorable association.
ACC, LUSC, and UCS are the cancer types where RPS14P5 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.